Accueil/Actions/PACB

PACB

USD

Pacific Biosciences of California Inc. Common Stock

$1.760+0.020 (1.149%)

Prix en Temps Réel

Healthcare

Dispositifs médicaux

États-Unis

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché

Fondamentaux de l'Entreprise

Statistiques de Trading

Métriques de Marché

Ouverture

$1.740

Haut

$1.790

Bas

$1.630

Volume

10.33M

Fondamentaux de l'Entreprise

Capitalisation Boursière

531.4M

Industrie

Dispositifs médicaux

Pays

United States

Statistiques de Trading

Volume Moyen

8.24M

Bourse

NMS

Devise

USD

Intervalle sur 52 Semaines

Bas $0.85Actuel $1.760Haut $2.66

Actualités Connexes

10 nov. 2025 · 14:16

Analyst Upgrades

Stephens & Co. Maintains Overweight on Pacific Biosciences, Raises Price Target to $2

Stephens & Co. analyst Mason Carrico maintains Pacific Biosciences with a Overweight and raises the price target from $1.8 to $2.

Stephens & Co. Maintains Overweight on Pacific Biosciences, Raises Price Target to $2

4 nov. 2025 · 14:05

GlobeNewswire

PacBio Supports Berry Genomics in Achieving First Regulatory Approval for Clinical Long-Read Sequencing in China

MENLO PARK, Calif., Nov. 04, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB), developer of the world's most advanced sequencing technologies, today announced that, through its long-standing partnership with Berry

PacBio Supports Berry Genomics in Achieving First Regulatory Approval for Clinical Long-Read Sequencing in China

22 oct. 2025 · 20:05

GlobeNewswire

PacBio to Report Third Quarter 2025 Financial Results on November 5, 2025

MENLO PARK, Calif., Oct. 22, 2025 (GLOBE NEWSWIRE) -- PacBio (NASDAQ:PACB) announced today that it will hold its quarterly conference call to discuss its third quarter 2025 financial results on Wednesday, November 5,